Watch ASPN. Know when insiders buy.
One email the day a filing lands. Free.
ASPN
ASPEN AEROGELS INC
4.92
+0.14 +2.93%
USD · close Sep 4
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
74
PASS · shorts 74
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $408.3MP/E —DIV YIELD —FCF YIELD 8.42%REV TTM $202.1M −49.1%NET INCOME −$126.2MNET CASH $94.7M52W 2.57 – 8.82SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $49.8M | −36.1% | 6.5% | −$28.8M | −$23.3M | — | -0.28 | −$16.2M | $1.8M | −$18M | Aug 7 |
| Q1 2026 · Mar 31 | $37.9M | −51.9% | 11.3% | −$20.8M | −$23.7M | — | -0.29 | $34.1M | $1.4M | $32.8M | Aug 7 |
| Q4 2025 · Dec 31derived | $41.3M | −66.4% | -55.5% | −$70.4M | −$72.9M | −741.7% | -0.88 | $16.1M | $2.5M | $13.7M | Mar 23 |
| Q3 2025 · Sep 30 | $73M | −37.8% | 28.5% | −$3.3M | −$6.3M | — | -0.08 | $15M | $9.1M | $5.9M | Nov 6 |
| Q2 2025 · Jun 30 | $78M | −33.7% | 32.4% | −$5.2M | −$9.1M | −153.8% | -0.11 | −$3.9M | $12.9M | −$16.8M | Aug 7 |
| Q1 2025 · Mar 31 | $78.7M | −16.7% | 29.0% | −$299.3M | −$301.2M | — | -3.67 | $5.6M | $13M | −$7.4M | Aug 7 |
| Q4 2024 · Dec 31derived | $123.1M | +46.2% | 38.3% | $14.7M | $11.4M | — | 0.14 | $35.7M | $14.8M | $20.9M | Mar 23 |
| Q3 2024 · Sep 30 | $117.3M | +93.1% | 41.8% | $17.4M | −$13M | — | -0.17 | $20.8M | $20.8M | −$50K | Nov 6 |
| Q2 2024 · Jun 30 | $117.8M | — | 43.8% | $20M | $16.8M | — | 0.21 | $6.8M | $24.8M | −$18M | Nov 6 |
| Q1 2024 · Mar 31 | $94.5M | — | 37.2% | $2.4M | −$1.8M | — | -0.02 | −$17.7M | $25.9M | −$43.6M | Nov 6 |
| Q4 2023 · Dec 31derived | $84.2M | — | 35.2% | $1.4M | −$519K | — | -0.01 | −$2.8M | $27.8M | −$30.6M | Mar 23 |
| Q3 2023 · Sep 30 | $60.8M | — | 22.7% | −$14.6M | −$13.1M | — | -0.19 | −$7.5M | $32.3M | −$39.8M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $271.1M | 17.0% | −$378.2M | −$389.6M | -143.7% | -4.73 | $32.9M | $37.4M | −$4.6M | — | — |
| FY2024 · to Dec 31 | $452.7M | 40.4% | $54.5M | $13.4M | 3.0% | 0.17 | $45.5M | $86.3M | −$40.7M | — | — |
| FY2023 · to Dec 31 | $238.7M | 23.8% | −$49.2M | −$45.8M | -19.2% | -0.66 | −$42.6M | $175.5M | −$218.1M | — | — |
| FY2022 · to Dec 31 | $180.4M | 2.8% | −$79.2M | −$82.7M | -45.9% | -2.10 | −$94.4M | $178M | −$272.4M | — | — |
| FY2021 · to Dec 31 | $121.6M | 8.2% | −$40.6M | −$37.1M | -30.5% | -1.22 | −$18.6M | $13.8M | −$32.4M | — | — |
| FY2020 · to Dec 31 | $100.3M | 14.6% | −$21.6M | −$21.8M | -21.7% | -0.83 | −$9.9M | $3.4M | −$13.3M | — | — |
Every number comes from ASPEN AEROGELS INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.